Our preferred vendors can help you unlock the potential within your practice.
These three companies have worked with NeuroStar and our practices extensively, and not only know their business, they know yours and can help you succeed at your goals. Scroll down for detailed package information from each vendor for Website Optimization, Paid Social Media, and Paid Search Marketing.
Choose a vendor and package to help you optimize your existing website pages, or create new content to promote your NeuroStar practice.
Whether you’re getting started with Paid Social Media, or optimizing your current ads, pick a vendor and package that best suits your needs and your budget.
Search Engine Marketing can be a powerful tool in the right hands. Fortunately these vendors and packages are designed to help you succeed, no matter your level of experience. Pick a vendor and a package, and get visible on Google today!
Copyright @ 2024 Neuronetics. All Rights Reserved.
Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.
Copyright @ 2021 Neuronetics. All Rights Reserved.
Visit https://neurostar.com for indications for use and safety information
